We would love to hear your thoughts about our site and services, please take our survey here.
Everything today is oversold, a second wave was largely priced in and so there is no room for a crash like March. If the ftse had recovered to near the 7000 mark prior to today then a bloodbath was possible but it an't dropping into the 4000s, that's for sure.
I said it would hold its own somewhat noggers, apologies for that. Hopefully will recover this week.
Thanks for your reply Inferno. Having followed boohoo for about a year without committing I finally bought in when the sp crashed in July, fortunately getting them at 240p. It's helpful to have more of a background to this company but if anything it strengthens the investment case. It looks like the time many years ago that you're referring to actually saw a much higher P/E than we have currently despite yet proving itself for any length of time and with questionable management. The problems you described have been put to bed somewhat and sales are expected to grow enormously this year due to the coronavirus accelerating the move online for retail. Feels like it could be coming together for the company...
I probably should have avoided throwing out the £7 figure as it makes me look amateurish but I was just pointing out the likely sp come the end of the year if the company returns to the P/e levels it saw before the slavery allegations emerged.
I've been crunching the numbers this evening as I'm trying to decide whether to really go large tomorrow. Currently Boohoo is my fourth largest holding but I'm starting to wonder if I should put all my available cash in here tomorrow.
It appears Boohoo grew rapidly until the sp hit a stumbling block in June 2017 and from there the sp is currently only ~25% higher. At that time Boohoo were generating between £300m and £500m a year of revenue and profit of about £30m. The first three months of the year this year Boohoo brought in £367m! This was during a strict lockdown in which buying clothes was seen as putting delivery drivers at risk and therefore somewhat crass...
With Oasis and Warehouse only recently coming online and PLTs major launch in the middle east, we could easily see revenue far greater than £2b and a sp around the £7 mark. Yeah, decision made. Any share weakness this week and I'm all in. GLA!
What gives me hope is that despite synairgen being a tiny company spun off from Southampton University, the scientists involved are highly respected and will have the ear of the likes of Chris Whitty and Patrick Vallance. I've seen numerous minutes of meetings involving both Vallance and Holgate for example... and sure government ministers tend to kowtow to big pharma but this is not normal times. I think Boris will be focused on himself and his legacy right now, not keeping his pals happy.
What is the all time high? When you look at charts the peak appears to be 491p but then HL and other sites have a different figure in the 517p - 529p range... Did it open up one day in the 500s?
The US performed a record one million tests on Saturday – but experts say the country needs to be hitting targets of between six and ten million a day to get the outbreak under control.
The country carried out 1,061,411 tests on Saturday, according to data from The COVID Tracking Project, a volunteer-run effort to track the outbreak.
I also noticed India has been administering over one million tests a day for some time now. How hard can it really be for us to sell at capacity??? Graham's 'H2 should exceed H1 sales' is grossly underestimating what we're currently selling... I just hope we don't have to wait til the end of the year for an update!
Sure I'll answer your point CS from my perspective as I'm not attempting to hide from your question:
There are of course two ways of interpreting Graham's comments in the latest half year update. One is the way you're interpreting it which is that the company is hiding behind lacklustre figures for the second half of the year and for that reason are holding sales figures back. If indeed I agreed with you and thought H2 was about the same as H1 I'd sell up now and run for the hills.
The other is the way I'm interpreting it - he's playing it down for sensitivity reasons. There is almost no way that the figures for H1 are in anyway comparable to H2. How do I know this? Well on June 2nd sales and contracted orders were €135m. Now sales for H1 were €72m, which leaves €63m of contracted orders for the second half of the year from June 2nd alone!
That makes it pretty damn obvious that sales will be considerably higher in H2 than in H1 and therefore confirms that Graham is indeed playing it down so as to avoid negative headlines that suggest the firm is profiteering to such a degree from a crisis...
At this point it's obvious that you've got a bone to pick CS and you just won't leave it alone. You were desperate for a 'I told you so' moment and it hasn't come. Novacyt has made steady progress for months now with every chance of a breakout soon and you're trying your hardest to bring some negativity and doubt to the board once again... sadly for you it's not going to happen. However you try to spin it the future looks rosy for ncyt. Over the past three months (when your deramping hit fifth gear) the sp has almost doubled... and it's only going one way. There will likely be individuals on here that panicked due to all your scare mongering and missed out on some very healthy returns...
It's about time you showed some class and accepted that you were wrong.
gggg there is no doubt that if high street retailers think they've had it bad so far, they've got another thing coming. Are people likely to get on public transport to reach the high street to put on a mask to wander through a clothes shop in which they aren't even allowed to use the fitting rooms and try stuff on? Frankly no.
I can assure you that if it was a negative article every comment would be along the lines of 'Fools by name, fools by nature', 'Biggest load of tosh, who pays these numbskulls for this drivel?!'
I read the motley fool however and have learnt over time what to take away and what to ignore, and most importantly which contributors are worth their salt. Boohoo has become possibly the favourite stock on there over the past month and for good reason - it's a winner and the most exciting growth stock around...
I think we can comfortably expect two full years of exceptional covid test sales - not the one we originally thought back in April...
A few months ago when we had more or less one covid test being sold we got the news that ncyt were scaling up to 10 million tests. From that we extrapolated revenue of ~£45m if selling at capacity. Since then we have brought a whole range of tests to, most notably the winterplex, with more in the pipeline. Does anyone know what sort of capacity ncyt/primer are working at now? I have absolutely no idea to be honest how revenue is likely to be broken down now and that does concern me seeing as I'm so heavily invested here!
If anyone can sort of layout what we're looking at it would be very much appreciated.
It's brilliant and so is Edward Norton.
Reservoir Dogs
Taxi Driver
American History X
In Bruges
Sorry that was meant to say 'Only those businesses most at risk of bankruptcy will be badly hit by a lockdown - I think NEX has found its bottom...
Noggers, hear me out... I've been thinking a lot about this over the past 24 hours.
What happened in February/March was very different. It was a major shock to the markets and each escalation caused another little tremor until March 23rd, the day the lockdown began, when the markets rapidly recovered some of their huge losses. This time is different. It was expected, 'inevitable' as described by Boris this time. The markets have been ready for this for the past few months. It's why the likes of NEX, a fundamentally sound business, couldn't catch a break back to the 200s.
This time will be different. Share prices will not crash indiscriminately. Lockdowns will be somewhat localised and much shorter. Any falls will be quickly bought into. Only those businesses most at risk of bakruptcy will be badly hit. I think lockdown or not NEX has found its bottom...
I reacted Friday by selling my riskiest contrarian stocks - CINE & RR. I then topped up on synairgen and novacyt (covid related stocks) and a little more in NEX.